Related references
Note: Only part of the references are listed.Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha (HNF1A) mutation
Frank Griscelli et al.
STEM CELL RESEARCH (2018)
TAT-mediated intracellular delivery of carboxypeptidase G2 protects against methotrexate-induced cell death in HepG2 cells
Issa Sadeghian et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Induced pluripotent stem cell technology: a decade of progress
Yanhong Shi et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
Bruce N. Cronstein et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Generation of Multilayered 3D Structures of HepG2 Cells Using a Bio-printing Technique
Hyeryeon Jeon et al.
GUT AND LIVER (2017)
Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis
Vincenzo Prestigiacomo et al.
PLOS ONE (2017)
Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis
Oksana Sirenko et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
Preventing and Managing Toxicities of High-Dose Methotrexate
Scott C. Howard et al.
ONCOLOGIST (2016)
Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues
Leah M. Norona et al.
TOXICOLOGICAL SCIENCES (2016)
Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma
Atsushi Takai et al.
SCIENTIFIC REPORTS (2016)
Long-term culture and expansion of primary human hepatocytes
Gahl Levy et al.
NATURE BIOTECHNOLOGY (2015)
Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
Richard Siller et al.
STEM CELL REPORTS (2015)
Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes
Anna-Karin M. Sjogren et al.
ARCHIVES OF TOXICOLOGY (2014)
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming
Yuanyuan Du et al.
CELL STEM CELL (2014)
Direct Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes
Pengyu Huang et al.
CELL STEM CELL (2014)
Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liver
David C. Bartlett et al.
CYTOTHERAPY (2014)
A review of methotrexate-associated hepatotoxicity
Roopjeet K. Bath et al.
JOURNAL OF DIGESTIVE DISEASES (2014)
Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant
Takanori Takebe et al.
NATURE PROTOCOLS (2014)
Vitamin C enhances anticancer activity in methotrexate-treated Hep3B hepatocellular carcinoma cells
Giou-Teng Yiang et al.
ONCOLOGY REPORTS (2014)
Accurate Prediction of Drug-Induced Liver Injury Using Stem Cell-Derived Populations
Dagmara Szkolnicka et al.
STEM CELLS TRANSLATIONAL MEDICINE (2014)
Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells
Su Mi Choi et al.
HEPATOLOGY (2013)
Identification of small molecules for human hepatocyte expansion and iPS differentiation
Jing Shan et al.
NATURE CHEMICAL BIOLOGY (2013)
Production of hepatocyte-like cells from human pluripotent stem cells
Nicholas R. F. Hannan et al.
NATURE PROTOCOLS (2013)
Highly Efficient Differentiation of Functional Hepatocytes From Human Induced Pluripotent Stem Cells
Xiaocui Ma et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
In vitro models for liver toxicity testing
Valerie Y. Soldatow et al.
TOXICOLOGY RESEARCH (2013)
JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy
Kris Vaddi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol
Yu-Fan Chen et al.
HEPATOLOGY (2012)
Modeling hepatitis C virus infection using human induced pluripotent stem cells
Robert E. Schwartz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line
Stephen J. Fey et al.
TOXICOLOGICAL SCIENCES (2012)
Opportunities for Use of Human iPS Cells in Predictive Toxicology
B. D. Anson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver
Karima Begriche et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatotoxicity related to antirheumatic drugs
Guruprasad P. Aithal
NATURE REVIEWS RHEUMATOLOGY (2011)
Highly Efficient Generation of Human Hepatocyte-Like Cells from Induced Pluripotent Stem Cells
Karim Si-Tayeb et al.
HEPATOLOGY (2010)
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells
S. Tamir Rashid et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity
Stefan Russmann et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis
J. A. M. Wessels et al.
RHEUMATOLOGY (2008)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Share Paper
